Carriers of the NFkB -94del were at 1.45-fold (95% confidence interval (CI): 1.10-1.92) higher risk of CRC than homozygous carriers of the ins allele (Table 2) whereas PXR and LXR genotypes were not associated with CRC risk (Table 2). Here, NFKB1 is linked to colorectal carcinoma.